Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Mol Cell Biochem. 2020 Aug 10;473(1-2):39–50. doi: 10.1007/s11010-020-03806-7

Table 1.

Experimental Design

Study Days
Treatment Groups 1 2 3 4
Group 1 (n=4 males, n=5 females) V sca V sc V sc V sc
Group 2 (n=4 males, n=5 females) V sc V sc V sc INS scb
Group 3 (n=5 males, n=5 females) INS scc INS scc INS scc INS scb
a

vehicle administered by subcutaneous route

b

30.0 U neutral protamine Hagedorn insulin (INS)/kg bw sc

e

5.0 U neutral protamine Hagedorn insulin (INS)/kg bw sc